Get started
Author

Carmé García-Benito

Observed names: C. García-Benito, Carme Garcia-Benito, Carme García-Benito, Carme García‐Benito
ORCID: 0000-0003-2583-8769
Observed ORCID: 0000-0003-2583-8769
OpenAlex ID: A5035799415
Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC
2022 · Ana Oitabén, Pablo Fonseca, et al. · Cancers · 27
PDF
Safety and efficacy of encorafenib–cetuximab combination in BRAF-mutated metastatic colorectal cancer: real-world evidence from the CONFIDENCE Spanish multicenter study
2024 · A. Fernández-Montes, J. Ros, et al. · ESMO Real World Data and Digital Oncology · 5
PDF
Genomics guiding personalized first-line immunotherapy response in lung and bladder tumors
2025 · Jenifer Brea-Iglesias, María Gallardo-Gómez, et al. · Journal of Translational Medicine · 3
PDF
Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study)
2025 · Silvia Masini, Monica Antoñanzas Basa, et al. · Cancers · 1
PDF
Long‐Term Colorectal Cancer Incidence After Adenoma and Serrated Polyp Removal: Results From the Colonprev Trial
2026 · Joaquín Cubiella, Carme García‐Benito, et al. · United European Gastroenterology Journal
A cross-sectional analysis from a real-world cohort of patients with microsatellite instability colorectal cancer (MSI-CRC) with metastatic disease from the Spanish RETUD registry.
2025 · Cristina Gravalos Castro, Sandra López, et al. · Journal of Clinical Oncology
PDF
A cross-sectional analysis from a real-world cohort of patients with microsatellite instability colorectal cancer (MSI-CRC) with localized disease from the Spanish RETUD registry.
2025 · Ana Fernandez Fernandez Montes, Carolina Muriel Lopez, et al. · Journal of Clinical Oncology
PDF
Works count: 7
Citation count: 36
H-index: 3
I10-index: 1
Year
Topic
Type